Cornell University

Medications

New insight into old IBD drug could improve treatments

Although it is one of the oldest medications used to treat patients with inflammatory bowel disease (IBD) and an effective treatment for an associated arthritis condition called spondyloarthritis (SpA), sulfasalazine's mechanism ...

Diseases, Conditions, Syndromes

Light, labor inducer could treat skin condition vitiligo

Patients with an appearance-altering skin condition may have relief thanks to an unlikely cocktail of a molecule that induces labor, an immunosuppressant medication and controlled UVB irradiation.

Oncology & Cancer

Stromal cells may help predict prostate cancer metastasis

Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors' potential to spread, and may even be targets for future prostate cancer treatments, according ...

Oncology & Cancer

Combination treatment improves lung cancer outcomes, finds study

A new study has found that patients with non-small cell lung cancer (NSCLC) treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received immunotherapy ...

Neuroscience

Mapping brain repair and remodeling after stroke

Researchers at Weill Cornell Medicine have cataloged the cellular response to stroke in a preclinical model, identifying the immune cells involved and the roles they may play in the days and weeks following a stroke.

Diabetes

Under-the-skin implant could treat type I diabetes

A collaboration between researchers from Cornell and University of Alberta, Edmonton, has created a new technique to treat type 1 diabetes: implanting a device inside a pocket under the skin that can secrete insulin while ...

page 2 from 40